MedTrace Logo

Evaluation 2% Chlorhexidine Gluconate

NCT03326726 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-09-28

Study results available
· View outcomes & findings →

Summary

Medline 2% CHG cloth (Active) - A single cloth from the pack was used per treatment area. The investigational test article was applied topically by vigorously scrubbing the skin in a back and forth motion for three minutes (and halfway through the 3-minute application time, the cloth was turned over) over the treatment area (7" x 10" of the subject's back), and the skin was allowed to air dry.

Conditions

  • Skin Coverage

Interventions

DRUG

2% CHG

Chlorhexidine Gluconate

Sponsors & Collaborators

  • Medline Industries

    lead INDUSTRY

Principal Investigators

  • Hamid Bashir · Microbac Laboratories, Inc.

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-16
Primary Completion
2016-11-18
Completion
2016-11-18
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03326726 on ClinicalTrials.gov